|
World Health Organization Public Inspection Reports (WHOPIR)
Introduction to WHOPIRs
The World Health Organization Public Inspection Reports (WHOPIR) is a summary of the inspection report of
-
a manufacturing site for Active Pharmaceutical Ingredients (APIs);
- a manufacturing site for Finished Products (FPs);
- an organization such as a Contract Research Organization where a
bioequivalence study or other clinical study had been performed (CROs);
- a quality control laboratory
The WHOPIR reflects the inspection report and gives a summary of the
observations and findings made during the inspection, but excludes
confidential proprietary information. It indicates also the date and
duration of the inspection as well as the scope of the inspection.
Manufacturing sites are subjected to periodic inspections and follow
up inspections. The implementation of the corrective actions is
verified by WHO by means of a documentation review or a follow-up
inspection. Only when all critical or major non-compliances" with
WHO GMP, GCP or other equivalent guidelines have been satisfactorily
corrected by the manufacturers or organizations, the sites are
published on the list and the WHOPIR are issued.
Although the manufacturing sites might have been inspected several
times, only the WHOPIR of the last inspection, mentioned in the
list, is available.
Regarding the CRO's, because the inspections are study specific, the
WHOPIR of the CRO is built up by the results of the different
successive inspections. It will mention along with a summary of the
observations made during the different inspections, all the studies
conducted, inspected and accepted, as well as the dates of
inspection for each study.
Public inspection reports are published on this WHO Prequalification
web page as WHOPIRs in response to Resolution WHA57.14 of the World
Health Assembly, dated 22 May 2004, which requested the
Director-General:
"...to ensure that the prequalification review process and the
results of inspection and assessment reports of the listed products,
aside from proprietary and confidential information, are publicly
available".
Manufacturing sites and
activities at those sites may undergo change. All users of
the List of Prequalified Products and WHOPIRs are therefore
advised to verify with the relevant manufacturer(s) that production and
control activities on site have not changed since WHO
inspection. Each WHOPIR remains on the web site for 3 years,
after which period it is moved to the section named "Archived
WHOPIRs".
Requests for copies of the complete inspection reports should be
sent to the individual manufacturers or organizations.
WHOPIRs by Category
Manufacturers of Finished Pharmaceutical Products (FPPs)
-
Ajanta Pharma Ltd, Paithan (27-30 June 2011), Aurangabad - INDIA
[pdf]
-
Ajanta Pharma Ltd, Paithan (31 August-3 September 2009),
Aurangabad - INDIA [pdf]
-
Aspen Port Elizabeth (Pty) Ltd - Republic of SOUTH
AFRICA
[pdf]
-
Beijing Novartis Pharma Ltd (26-29 September 2011),
Beijing - CHINA [pdf]
-
Beijing Novartis Pharma Ltd (16-17 March 2009), Beijing
- CHINA [pdf]
-
Cadila Pharmaceuticals Ltd (11-14 April 2011), Ahmedabad
- INDIA [pdf]
-
Cadila
Pharmaceuticals Ltd (6-7 December 2010), Ahmedabad -
INDIA [pdf]
-
Cadila Pharmaceuticals Ltd (13-17 March & 20-22 August
2008), Ahmedabad - INDIA
[pdf]
-
CIPLA
Ltd - Unit 8 (21-24 September 2011), Goa - INDIA
[pdf]
-
CIPLA Ltd (21-24 February 2011), Patalganga - INDIA
[pdf]
-
CIPLA Ltd (14-17 February 2011), Goa - INDIA
[pdf]
-
CIPLA
Ltd (6-9 September 2010), Units III, IV and VII, Goa -
INDIA [pdf]
-
CIPLA
Ltd (6-9 September 2010), Unit IX, Goa - INDIA [pdf]
-
CIPLA
Ltd (16-19 August 2010), Indore - INDIA [pdf]
-
CIPLA Ltd (9-12 August 2010), Patalganga - INDIA
[pdf]
-
CIPLA
Ltd, Plot D7, D-22 (16-19 September 2009), Kurkumbh -
INDIA [pdf]
-
CIPLA Ltd, Unit I, III, IV, VII (6-7 August 2009), Goa -
INDIA [pdf]
-
CIPLA Ltd (23-26 March 2009), Baddi - INDIA [pdf]
-
Emcure Pharmaceuticals Ltd (8-11
March 2010), Pune - INDIA [pdf]
-
Famy Care Ltd (7-9 September 2011), Mumbai - INDIA
[pdf]
-
Guilin
Pharmaceutical Co, Ltd (23-26 August 2010), Guangxi -
CHINA [pdf]
-
Guilin
Pharmaceutical Co, Ltd (25-26 February 2010),
Guangxi - CHINA [pdf]
-
Hetero
Labs Ltd, Unit V (23-26 November 2010), Andhra Pradesh -
INDIA [pdf]
-
Hetero Drugs Limited, Unit-III, Block A and B (25-28 August 2009), Hyderabad
- INDIA [pdf]
-
Hetero Drugs Limited, Unit III, (3-4 August 2009),
Hyderabad - INDIA [pdf]
-
IPCA Laboratories Ltd (7-10 February 2011), Pithampur - INDIA [pdf]
-
Joint Stock Company JSC "Biocom" (8-12 November 2010),
Stavropol - RUSSIA [pdf]
-
Lupin Ltd (16-19 August 2011), Jammu - INDIA
[pdf]
-
Lupin Ltd (09-10 December 2010),
Aurangabad - INDIA [pdf]
-
Lupin Limited, Rifa and
Non-Rifa block N° 2 (29 September-2 October 2009),
Aurangabad - INDIA [pdf]
-
Macleods
Pharmaceuticals Ltd (15-19 February 2010), Kachigam,
Daman - INDIA [pdf]
-
Macleods Pharmaceuticals Ltd, Unit VI (17-20 March
2009), District Solan - INDIA [pdf]
-
Maphar Laboratories (8-11 February
2010), Casablanca - Morocco
[pdf]
-
Matrix Laboratories Limited, Unit OSD, (10-11 August 2009), Nashik District - INDIA [pdf]
-
Matrix
Laboratories Ltd, Unit 8 PB9,
(25-28 May 2009), Andhra Pradesh - INDIA [pdf]
-
Meditab Specialities Pvt. Ltd (19-22 April 2011), Satara
- INDIA [pdf]
-
Meditab Specialities Pvt Ltd (8-11 February 2011), Goa -
INDIA [pdf]
-
Meditab Specialities Pvt Ltd
(27-30 January 2009), Goa - INDIA [pdf]
-
Micro Labs Limited (15-18 March 2010), Goa - INDIA [pdf]
-
Micro Labs Limited (18-21 May 2009), Hosur - INDIA [pdf]
-
Mission Vivacare Limited (28-31 March 2011), Pithampur -
INDIA [pdf]
-
Novartis Pharmaceuticals Corporation (25-28 October
2010), Suffern, NY - USA [pdf]
-
Quality
Chemical Industries Ltd (QCIL) - (25-28 January 2010),
Kampala - UGANDA [pdf]
-
Ranbaxy
Laboratories Limited (23-26 August 2011), Mohali - INDIA
[pdf]
-
Ranbaxy Laboratories Limited, Unit I & II (18-21 April
2011), Paonta Sahib - INDIA [pdf]
-
Ranbaxy
Laboratories Limited (23-25 November 2009), Paonta Sahib -
INDIA [pdf]
-
Sandoz
Private Limited (14-17 February 2011), Navi Mumbai -
INDIA [pdf]
-
Sandoz SA (Pty) Ltd (12-15 April 2010), Kempton Park -
Republic of SOUTH AFRICA [pdf]
-
Strides
Arcolab Limited (13-14 December 2010), Bangalore - INDIA
[pdf]
-
Strides
Arcolab Limited, Oral solid dosage forms division (21-22
November 2009), Bangalore - INDIA
[pdf]
-
Strides
Arcolab Limited, Sterile Products Division (18-20
November 2009), Bangalore - INDIA
[pdf]
-
Strides Arcolab Limited, Sterile Products Division
(23-26 February 2009), Bangalore - INDIA [pdf]
-
Universal Corporation Ltd (13-16 June 2011), Kikuyu Town
- KENYA [pdf]
-
Varichem Pharmaceuticals (Pvt) Ltd (10-14 May 2010),
Harare - Zimbabwe
[pdf]
Manufacturers
of Active Pharmaceutical Ingredients (APIs)
-
Aptuit Laurus Private Limited (18-21 July 2011),
Visakhapatnam - INDIA [pdf]
-
Calyx Chemicals & Pharmaceuticals Limited (13-16 June
2011), Tarapur - INDIA [pdf]
-
Chongqing Holley Wullingshan Pharmaceutical Co, Ltd
(24-26 November 2010), Chongqing - CHINA [pdf]
-
CIPLA Ltd (27-30 June 2011), Bangalore - INDIA
[pdf]
-
CIPLA Ltd - Unit I & II (14-17 February 2011),
Patalganga - INDIA [pdf]
-
CIPLA Ltd (10-12 February 2011), Kurkumbh - INDIA
[pdf]
-
Hainan Poly Pharma Co Ltd (21-23 November 2011), Haikou
City - CHINA [pdf]
-
Hetero Drugs Limited (HDL) - Hetero Labs Limited (HLL) -
(20-23 June 2011), Andhra Pradesh - INDIA
[pdf]
-
Hetero
Labs Ltd, Unit-I (25-27 January 2011), Medak District -
INDIA [pdf]
-
Ipca Laboratories Limited (30 November-03 December 2010), Madhya Pradesh - INDIA
[pdf]
-
Kunming Pharmaceutical Corporation
(KPC), Phytochemistry Plant N° 4 (14-16 September
2009), Kunming - CHINA
-
Lupin Ltd (16-18 February 2011), Tarapur - INDIA
[pdf]
-
Lupin Limited (21-24 September 2009), Tarapur - INDIA
[pdf]
-
Mangalam
Drugs & Organics Ltd, Unit 1 (17-20 January 2011),
Gujarat - INDIA [pdf]
-
Matrix Laboratories Limited (14-16 February 2011), Medak District - INDIA
[pdf]
-
Mylan (former Matrix)
Laboratories Ltd (Unit-VIII) (15-19 August 2011), Vizianagaram District - INDIA [pdf]
-
Mylan Laboratories Ltd, Unit III (22-26 August 2011),
Hyderabad - INDIA [pdf]
-
Sequent Scientific Limited (SSL) (20-23 October 2009),
Karnataka - INDIA [pdf]
-
Shanghai
Desano Chemical Pharmaceuticals Co., Ltd (15-18 March
2011), Shanghai - CHINA [pdf]
-
Shanghai
Desano Chemical Pharmaceutical Co, Ltd (9-11 September
2009), Shanghai - CHINA [pdf]
-
Zhejiang
Medicine Co. Ltd (13-16 October 2010), Xinchang - CHINA
[pdf]
Contract
Research Organizations (CROs)
-
Accutest
Research Laboratories (I) Pvt Ltd (Unit-I) (26-27 September
2011), Navi Mumbai - INDIA [pdf]
-
Accutest Research Laboratories (India) Pvt Ltd (28-29
May 2009), Mumbai - INDIA [pdf]
-
Accutest Research Laboratories (India) Pvt Ltd (25-26
May 2009), Ahmedabad - INDIA [pdf]
-
BA
Research India Ltd (18-20 October 2010), Ahmedabad -
INDIA [pdf]
-
Bioserve Clinical Research (P) Ltd (19 May 2010),
Hyderabad - INDIA
[pdf]
-
Bombay Bioresearch Centre (BBRC) - (18-20 July 2011),
Mumbai - INDIA [pdf]
-
Bombay Bioresearch Centre (BBRC) - (18-20 May 2011),
Mumbai - INDIA [pdf]
-
Bombay Bioresearch Centre (BBRC) (11-15 October 2010) -
INDIA [pdf]
-
GVK
Biosciences Pvt Ltd (21-23 April 2009), Hyderabad -
INDIA [pdf]
-
Macleods Pharmaceuticals Ltd, (25-26 February 2009),
Mumbai - INDIA [pdf]
-
Matrix Laboratories Ltd (20-21 May 2010), Hyderabad -
INDIA
[pdf]
-
Matrix Laboratories Limited, Clinical Research Centre
(27-28 August 2009), Hyderabad - INDIA [pdf]
-
Matrix Laboratories Limited (22-23 July 2009),
Secunderabad - INDIA [pdf]
-
Piramal Clinical Research (20-24 June 2011), Ramanthapur
- INDIA [pdf]
-
Ranbaxy Laboratories Ltd, Department of Clinical
Pharmacology and Pharmacokinetics (24-26 August 2009),
Gurgaon - INDIA [pdf]
-
Semler Research Centre Pvt Ltd (11-15 July 2011),
Bangalore - INDIA [pdf]
-
Semler Research Center Pvt. Ltd (12-16 July 2010),
Bangalore - INDIA [pdf]
-
Shanghai Xuhui Central Hospital (15-17 June 2010),
Shanghai - CHINA [pdf]
-
Sitec Labs Pvt Ltd (23-24 February 2009), Mumbai - INDIA
[pdf]
-
Synchron Research Services (Pvt) Ltd (17 May 2010),
Ahmedabad - INDIA
[pdf]
-
Veeda Clinical Research Pvt. Ltd (20-21 July 2009),
Ahmedabad - INDIA [pdf]
Quality Control
Laboratories
-
Adcock Ingram Ltd (18-20
April 2011), Johannesburg - Republic of SOUTH AFRICA
[pdf]
-
Central Laboratory for Quality
Control of Medicines and Medical Products, State
Inspection for Quality Control of Medicines (15-16 December 2009), Kiev -
UKRAINE [pdf]
-
Ezequiel Dias Foundation Octavio Magalhães Institute
(IOM) Medicines Service Laboratory (23-25 March 2011),
Belo Horizonte - BRAZIL [pdf]
-
Health Sciences Authority (9-10 March 2009), Singapore -
SINGAPORE [pdf]
-
Laboratory of Pharmaceutical Analysis, "State
Pharmacological Centre", Ministry of
Health of Ukraine
(17-18 December 2009), Kiev -
UKRAINE [pdf]
-
Laboratory of the Mission for Essential Drugs & Supplies
(MEDS)-(3-4 February 2009), Nairobi - KENYA [pdf]
-
Scientific Centre on Expertise of Medical Application
Products (24-27 January 2011), Moscow - RUSSIA
[pdf]
-
TÜV SÜD PSB Singapore (21-22 October 2008 & 13 March
2009) - SINGAPORE [pdf]
-
Vimta
Labs Limited (20-22 December 2010), Hyderabad - INDIA
[pdf]
The WHOPIR is the property of the
World Health Organization and may not be copied, reproduced, abstracted,
edited, translated, distributed or used in any way, without the prior
written authorization of WHO. In no event may this report be used for
any commercial and/or promotional purposes.
After a period of three years, WHOPIRs are moved to the
section marked "Archived WHOPIRs". If a site is inspected
and found to be non-compliant with GMP after a WHOPIR was
issued following
a previous inspection, that WHOPIR will be removed from the
web site (as the site is then no longer considered compliant
with GMP).
Related links:
|